Uta Kemmerich-Keil

Ms. Uta Kemmerich-Keil is an Independent Non-Executive Director at British American Tobacco plc, an Independent Member-Supervisory Board at Beiersdorf AG and a Co-Managing Director at Chemitra GmbH.
She is on the Board of Directors at Lanxess AG, British American Tobacco plc, Beiersdorf AG, FARCO-PHARMA GmbH, Klosterfrau Zürich AG, Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mbH, Röchling SE & Co. KG and SCHOTT AG.
Ms. Kemmerich-Keil was previously employed as a Member-Supervisory Board by Biotest GmbH & Co. KGaA, a Member-Supervisory Board by Affimed NV, an Independent Director by Karo Healthcare AB, a CEO-Personal Healthcare International by Procter & Gamble AG, a President & Chief Executive Officer by Merck Consumer Health Holding GmbH, a President & CEO-Merck Consumer Health Division by Merck KGaA, a Senior Financial Auditor by Hoechst AG, an Assistant Professor-Roman Philology Department by University of Freiburg, a Chief Executive Officer by Allergopharma Joachim Ganzer KG, and a Co-Managing Director by Merck Selbstmedikation GmbH.
She also served on the board at GOTHAER Versicherungsbank VVaG.
She received her undergraduate degree from the University of Freiburg and a graduate degree from the University of Freiburg.